ABBOTT PARK, Ill. and NEW YORK, Sept. 19, 2023 /PRNewswire/ -- Abbott (NYSE: ABT) and WW International, Inc. (WW) (NASDAQ: WW), known as WeightWatchers, announced today the availability of a connected ...
Abbott Laboratories and WeightWatchers have launched a connected app to help people living with diabetes understand how food and activity impact their glucose levels. WeightWatchers members who follow ...
A year after joining forces with a goal of improving health management for people with Type 2 diabetes, Abbott and WeightWatchers’ partnership has borne fruit. The pair has now officially launched ...
Just a short while after securing a CE Mark for its second generation device, Abbott has been granted FDA clearance for FreeStyle LibreLink, a companion mobile app for its 10 to 14-day CGM. The launch ...
WeightWatchers is the most popular weight-loss program doctors recommend. The WW Diabetes-Tailored Plan has been shown to lower members' haemoglobin A1c by 0.76 points and their diabetes discomfort by ...
ABBOTT PARK, Ill., Jan. 5, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), a leading healthcare company, today unveiled Libre Assist,1 a groundbreaking feature within the Libre app5 designed to help the ...
This morning med tech giant Abbott announced a new deal with chronic care management company Omada Health that will integrate Abbott’s FreeStyle Libre continuous glucose monitor (CGM) with Omada's ...
Abbott is tapping the spirit of new beginnings for the New Year by unveiling a “gamechanger" feature within the company’s Libre app: Libre Assist. Timed to launch during this week’s CES 2026 ...
Traditional food logging apps offer feedback after the fact—Libre Assist 1 offers help in-the-moment to inform mealtime decisions before every bite Libre Assist 1 leverages AI to predict how food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results